The Society of Thoracic Surgeons

Slides:



Advertisements
Similar presentations
Overview of Medicare’s Regulatory Programs Bob Jasak Deputy Director, Regulatory & Quality Affairs American College of Surgeons.
Advertisements

C hinese D atabase for C ardiovascular S urgery Questions and Thoughts Shengshou Hu M.D. President, Cardiovascular Institute & Fuwai Hospital Director,
Bree Collaborative Cardiology Report: Appropriateness of Percutaneous Cardiac Interventions (PCI) Bree Collaborative Meeting November 30, 2012.
NNEPQIN as a Patient Safety Organization NNEPQIN Fall Meeting November 14, 2009 Timothy J. Fisher, MD.
Grinols and Mustard Impact of a casino opening on crime rates Concern: casinos are not random – opened in struggling areas Data at county/year level –
NIH Mentored Career Development Awards (K Series) Part 4
Loyola University Chicago LOYOLA UNIVERSITY HEALTH SYSTEM Improving Care of Adult Patients Undergoing Cardiac Surgery LUMC CV-Surgical Team.
Learning Objectives Describe the use of the Outcomes Impact Analysis model to assess economic impact of a CME activity Discuss the potential role of Outcomes.
Clinical Trials. What is a clinical trial? Clinical trials are research studies involving people Used to find better ways to prevent, detect, and treat.
Overview Public Reporting Cardiovascular Data Recommendations.
Unit 1: Overview of HIV/AIDS Case Reporting #6-0-1.
1 Terri Conner,PhD Nybeck Analytics Partnership for Patients 14 th May 2012 USE OF MEDICARE DIAGNOSIS AND PROCEDURE CODES TO IMPROVE DETECTION OF SURGICAL.
0 IRIS A Qualified Clinical Data Registry Consumer-Purchaser Alliance September 9, 2014.
PSO Education for [agency/organization]’s PSES Workgroup (Presenter) (Date) 1 **For internal use by Center for Patient Safety PSO Participants. May not.
Lessons Learned from the Society of Thoracic Surgeons (STS) Congenital Database September 25, 2015 Robert J. Dabal, MD Associate Professor of Surgery.
PSO Overview for (name of organization’s) PSES Workgroup (Presenter) (Date) 1 **For internal use by Center for Patient Safety PSO Participants. May not.
MACRA Overview and RFI HIT Joint Committee October 6, 2015
© 2004 Moses & Singer LLP HIPAA and Patient Privacy Issues Raised by the New Medicare Prescription Drug Program National Medicare Prescription Drug Congress.
A NEW REIMBURSEMENT STRUCTURE FOR AMERICA ADVANCED DISEASE CONCEPTS.
UNIT-II CLINICAL DATA. UNIT-II CLINICAL DATA: Clinical Data, Application, Challenges, Solutions, Clinical Data Management System.
PATIENT SAFETY ORGANIZATION Michigan Surgical Quality Collaborative
Date of download: 6/24/2016 Copyright © The American College of Cardiology. All rights reserved. From: The Year in Cardiovascular Surgery J Am Coll Cardiol.
Promoting Health Information Technology Linda Magno Director, Medicare Demonstrations Group.
Current CMS Quality Reporting Programs Physician Quality Reporting System (PQRS) Electronic Health Records (EHR) Incentive Program (Meaningful Use) Value-Based.
MIPS Quality Component
Tim Friede Department of Medical Statistics
All-Payer Model Update
The New World of Physician Payments
Quality Reporting Office Hours
Use of Postmarket Data to Support Premarket Approvals
Improvement Activities
Chapter 33 Introduction to the Nursing Process
Quality Reporting Office Hours
Alternative Payment Models in the Quality Payment Program
Quality Reporting Office Hours
J. Matthew Brennan, MD, MPH Duke University School of Medicine
Lako S, Daka A, Nurka T, Dedej T, Memishaj S
Rhode Island Quality Institute
Quality Reporting Office Hours
Thank you for joining us today.
Introduction to the Quality Payment Program & MIPS
MCSQI Reasons for Prolonged Ventilation: N = 239
Michael Mack, M.D. Dallas, TX February 21, 2010
TCPI Data Management Webinar Eddie Fonner, Assistant Project Director
Work Group Purpose Identify Barriers Share Best Practices
Frederick L. Grover, MD  The Annals of Thoracic Surgery 
Public Reporting of Cardiovascular Data
Semiannual Report, March 2015
William Morgan, MD, Chief Clinical Officer,
PSO Overview for (name of organization’s) PSES Workgroup
Changes to HCC Criteria for Auto Approval
Accountable care organizations
All-Payer Model Update
Episode Payment Models: A Primer For Cardiology
Frederick L Grover, MD  The Annals of Thoracic Surgery 
Axon Registry: Background
PSO Overview for Executives
Quo vadimus? The Annals of Thoracic Surgery
How do the use and price of healthcare in the U. S
FDA Sentinel Initiative
2019 Improvement Activities
Graduate Subspecialty and Perceptions of Cardiothoracic Surgery Training: A 60-Year Retrospective Study  Mara B. Antonoff, MD, Jessica G.Y. Luc, MD, G.
PSO Overview for (name of organization’s) PSES Workgroup
PSO Overview for Executives
Component 11 Unit 7: Building Order Sets
Increase interdisciplinary communication
Value-Based Healthcare: The Evolving Model
MIPS Reporting - Quality
Sustainability and scalability Croatian Institute of Public Health
Implications of MACRA for Community Health Centers
Presentation transcript:

Qualified Clinical Data Registry (QCDR) Access to Medicare Claims Data: A Key to Value-Based Care The Society of Thoracic Surgeons Courtney Yohe, Director of Government Relations

What is a QCDR? Submits quality data to CMS Collects medical/clinical data Patient + disease tracking Quality of care improvement Medicare quality reporting requirements A Qualified Clinical Data Registry is a clinical data registry that has been certified by CMS to help physicians meet their quality reporting requirements. Clinical data registries have existed for much longer than QCDRs but, until recently, the definition of a QCDR was the only reference to clinical data registries in statute. SHOW OF HANDS – WHO HAS USED A QCDR FOR QUALITY REPORTING

Sec. 105b of MACRA Requires Access to Claims Data for QCDRs “…the Secretary shall, at the request of a qualified clinical data registry…provide the data…for purposes of linking such data with clinical outcomes data and performing risk-adjusted, scientifically valid analyses and research to support quality improvement or patient safety” Section 105b of MACRA requires CMS to provide QCDRs with access to Medicare claims data in order to facilitate and quality improvement. READ TEXT I’ve highlighted a few key words here: *LINK*claims data with clinical outcomes data contained in the QCDR Use the claims data for *RESEARCH* *QUALITY IMPROVEMENT, *PATIENT SAFETY* Linking means we have continuous access to the data. Not just discrete, episodic matching. Research, quality improvement, and patient safety have very different meanings as well. While research is governed by strict protections and protocols and is expected to result in publication, quality improvement and patient safety efforts have different guidelines and processes.

What is the STS National Database? Established in 1989 Gold standard Approved QCDR since program’s inception Physicians = best position to measure clinical performance accurately The STS National Database is one such QCDR that could perform quality improvement activities if linked to Medicare claims data. It was established in 1989 as an initiative for quality improvement and patient safety among cardiothoracic surgeons. The Database has since grown exponentially, both in terms of participation and stature, and has become the gold standard for clinical registries. The Society of Thoracic Surgeons believes that physicians are in the best position to measure clinical performance accurately and objectively.

There are three parts to the STS National Database There are three parts to the STS National Database. The Adult Cardiac Surgery Database captures more than 5.8 million cardiac surgery procedure records and has more than 3,000 participating physicians. In fact, it captures data on more than 95% of the adult cardiac surgical procedures being performed in the country. The General Thoracic Surgery Database contains over 435,000 general thoracic surgery procedure records and more than 875 participating surgeons. Finally, the Congenital Heart Surgery Database captures more than 373,000 congenital heart surgery procedure records and has more than 800 participating physicians.

The Database Effect Study of Coronary Artery Bypass Graft (CABG) surgery @ Database-participating institutions Decreased: Observed mortality Incidence of postoperative stroke Risk of reoperation for bleeding Incidence of sternal wound infection Our experience with the STS National Database has proven that, that by collecting data on individual cardiothoracic surgical procedures, doing analysis, and providing timely feedback to practicing surgeons improve care quality. El Bardissi and colleagues studied 1,497,254 patients who underwent isolated primary Coronary Artery Bypass Graft (CABG) surgery at STS National Database-participating institutions from 2000 to 2009. They found that: Patients received more indicated care. The observed mortality rate over this period declined from 2.4% in 2000 to 1.9% in 2009, representing a relative risk reduction of 24.4% . The incidence of postoperative stroke decreased significantly from 1.6% to 1.2%, representing a relative risk reduction of 26.4%. There was also a 9.2% relative reduction in the risk of reoperation for bleeding and a A 32.9% relative risk reduction in the incidence of sternal wound infection despite the acuity of patients increasing during this period of examination.

Virginia Cardiac Services Quality Initiative Another example of the database effect is the results of the Virginia Cardiac Services Quality Initiative. It started as a surgical collaborative designed to use the STS National Database to combine clinical and cost data to develop evidence-based protocols. It has since expanded to include cardiology as well. The critical aspect of this initiative is the linking of database data to cost data. Not only did VCSQI open up new ways to identify efficiencies in care, it also allowed surgeons in VA to measure the financial impact of quality interventions. For example, when VCSQI members noted high rates of blood transfusions, best practice protocols were identified and reproduced in the region. Transfusion rates fell by 40%. Because VCSQI had access to other sources of claims data, they were able to prove that this intervention resulted in $49M in savings over a two-year period. VCSQI created a novel clinical/financial tool by combining the robust clinical information found in the STS National Database with financial data. Such a tool, deployed at a national level, could have an incredible effect on the healthcare system and on quality-based payment reforms. This is one of the reasons we hoped that Section 105(b) would finally help us to solve our claims data access issues.

STS APM Goals: Improve quality Improve patient outcomes Reduce cost of care A logical extension of the VCSQI experience is for STS to develop its own Alternative Payment Model. As CMS continues to implement MACRA, If we can align payment to support data collection, feedback, and implementation of best practices, then ALL STAKEHOLDERS stand to benefit. We are submitting comments for the record at an Energy and Commerce Health Subcommittee this week that will describe our experience developing an APM and how it has been stymied by our inability to access claims data. Thus far we have been unable to benchmark our models and adjust for financial risk without being able to link claims information to desired quality outcomes.

The Fine Print Challenges remain: Access to data Benchmarking Despite the statutory mandate in MACRA, we’ve had a little trouble convincing folks at CMS to implement this provision correctly. In January 2016, CMS published a proposed rule that essentially said that registries already had access to claims data through the Research Data Assistance Center (ResDAC). (SHOW OF HANDS, WHO HAS ACCESSED DATA FROM RESDAC?) Defied statutory mandate Insufficient to meet our needs ResDAC requires an applicant to submit a new application for each data request – The ResDAC application process is long and cumbersome. ResDAC applications are approved for specific research projects not QUALITY IMPROVEMENT and/or new payment models. CMS walked back the ResDAC proposal in the final rule and proposed to modify the Qualified Entity (QE) program to allow registries to access claims data in the way that certain entities obtain data that they can provide or sell to providers for quality improvement. STS explored this program in its early years and found it lacking. Regional All provider types Although improvements have been made, it still leaves some to be desired. Currently, CMS intends that QCDRs use a hybrid process to get the claims data provided for under section 105(b) of MACRA. They suggest that we enter into the QE program for more direct linkages. However, if any publications are to be derived form that information, the QCDR must apply to ResDAC to use those same data. Clearly, this is not what was intended by Sec 105(b) though we are limited in our recourse. We can either have Congress push back on CMS or we can start to build a legal case.

QUESTIONS / DISCUSSION? Courtney Yohe Director of Government Relations The Society of Thoracic Surgeons cyohe@sts.org 202-787-1222